Trial Profile
A phase I study to evaluate the effect of obeticholic acid on the heart's electrical cycle, known as the QT interval in healthy volunteers
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2014
Price :
$35
*
At a glance
- Drugs Obeticholic acid (Primary)
- Indications QT interval prolongation
- Focus Adverse reactions
- 10 Nov 2014 New trial record